CRISPR engulfed in Intellectual Property debacle. What will this fight mean for the future of Synbio?

The United Kingdom’s Independent has released details of a debate amongst the originators of the CRISPR method of genome engineering continuing to rage this May. This battle for the monetary spoils of such a tremendous scientific advancement has gripped former colleagues at premier institutions on two continents. As the French team of Dr. Emmanuelle Charpentier…